| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 4e-05 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.27 | 5e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 7e-05 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.25 | 0.0003 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |